Catalyst Pharmaceuticals, Inc. (CPRX)
31.34
+0.06
(+0.18%)
USD |
NASDAQ |
Jun 09, 16:00
31.34
0.00 (0.00%)
After-Hours: 20:00
Catalyst Pharmaceuticals Research and Development Expense (Quarterly) : 2.661M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 13.75M |
| ADMA Biologics, Inc. | 2.597M |
| United Therapeutics Corp. | 138.20M |
| ANI Pharmaceuticals, Inc. | 10.60M |
| Indivior Pharmaceuticals, Inc. | 9.00M |